Association of cholesteryl ester transfer protein (CETP) polymorphisms with Alzheimer's disease

Chinese Journal of Neurology

Volumn 39, Issue 12, 2006, Pages 814-817

  Chen, Da Wei ^a   Chen, Biao ^b   Yang, Jing Fang ^b   Feng, Xiu Li ^b   Tang, Zhe ^b   Dong, Xiu Min ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Alzheimer disease; Apolipoproteins E; Carrier proteins; Polymorphism, single nucleotide

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL ESTER TRANSFER PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 34249905851     PISSN: 10067876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Mickikawa M. Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer' s disease? J Neurosci Res, 2003, 72: 141-146.
2. Chong PH, Kezele R, Franklin C. High-density lipoprotein cholesterol and the role of statins. Circ J, 2002, 66: 1037-1044.
3. Frikke-Schmidt R, Nordestgaard BG, Agerholm-Larsen B, et al. Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. J Lipid Res, 2000, 41: 1812-1822.
4. van der Steeg WA, Kuivenhoven JA, Klerkx AH, et al. Role of CETP inhibitors in the treatment of dyslipidemia. Curr Opin Lipidol, 2004, 15: 631-636.
5. Yamashita S, Hirano K, Sakai N, et al. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Biochim Biophys Acta, 2000, 1529: 257-275.
6. Rodriguez E, Mateo I, Infante J, et al. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele. J Neurol, 2006, 253: 181-185.
7. Arai H, Yamamoto A, Matsuzawa Y, et al. Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000. J Atheroscler Thromb, 2005, 12: 240-250.
8. Boekholdt SM, Thompson JF. Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J Lipid Res, 2003, 44: 1080-1093.
9. Fidani L, Goulas A, Crook R, et al. An association study of the cholesteryl ester transfer protein Taq I B polymorphism with late onset Alzheimer's disease. Neurosci Lett, 2004, 357: 152-154.
10. Zhu H, Gopalraj RK, Kelly JF, et al. Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimer' s disease. Neurosci Lett, 2005, 381: 3641.
11. Chinese source
12. Chinese source
13. Sakai N, Yamashita S, Hirano K, et al. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects. Atherosclerosis, 1995, 114: 139-145.
14. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res, 1990, 31: 545-548.
15. Bjorkhem I, Diczfalusy U, Lutjohann D. Removal of cholesterol from extrahepatic sources by oxidative mechanisms. Curr Opin Lipidol, 1999, 10: 161-165.
16. Olesen OF, Dago L. High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils. Biochem Biophys Res Commun, 2000, 270: 62-66.
17. Gong JS, Kobayashi M, Hayashi H, et al. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice. J Biol Chem, 2002, 27: 29919-29926.
18. Chinese source
19. Chinese source